Trial Profile
Preoperative Chemoradiotherapy In Non-Small Cell Lung Cancer (NSCLC) Patients With Operable Stage IIIB Disease: A Prospective Phase II Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jun 2018
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Cisplatin
- Indications Adenocarcinoma; Non-small cell lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 22 Jun 2018 New trial record